GOSS Gossamer Bio Inc

In a report released today, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Gossamer Bio (GOSS - Research Report), with a price target of $5.00. The company's shares closed yesterday at $2.16.Trucchio covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Gossamer Bio, and ATAI Life Sciences. According to TipRanks, Trucchio has an average return of -15.5% and a 30.28% success rate on recommended stocks. Currently, the analyst consensus on Gossamer Bio is a Moderate Buy with an average price target of $9.44, which is a 337.04% upside from current levels.
https://www.tipranks.com/news/blurbs/gossamer-bio-goss-gets-a-buy-from-h-c-wainwright-2?utm_source=advfn.com&utm_medium=referral